Aethlon Medical (AEMD) Competitors $0.38 0.00 (-1.26%) (As of 10:15 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends AEMD vs. PRPO, MDAI, IINN, PYPD, LFWD, MHUA, MBOT, NEPH, AMIX, and VVOSShould you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Precipio (PRPO), Spectral AI (MDAI), Inspira Technologies Oxy B.H.N. (IINN), PolyPid (PYPD), ReWalk Robotics (LFWD), Meihua International Medical Technologies (MHUA), Microbot Medical (MBOT), Nephros (NEPH), Autonomix Medical (AMIX), and Vivos Therapeutics (VVOS). Aethlon Medical vs. Precipio Spectral AI Inspira Technologies Oxy B.H.N. PolyPid ReWalk Robotics Meihua International Medical Technologies Microbot Medical Nephros Autonomix Medical Vivos Therapeutics Aethlon Medical (NASDAQ:AEMD) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings, risk and community ranking. Do analysts recommend AEMD or PRPO? Aethlon Medical currently has a consensus price target of $7.00, indicating a potential upside of 1,674.40%. Given Aethlon Medical's stronger consensus rating and higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Precipio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Precipio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, AEMD or PRPO? Aethlon Medical has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Do insiders & institutionals have more ownership in AEMD or PRPO? 2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 10.5% of Precipio shares are held by institutional investors. 1.1% of Aethlon Medical shares are held by insiders. Comparatively, 13.3% of Precipio shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is AEMD or PRPO more profitable? Aethlon Medical has a net margin of 0.00% compared to Precipio's net margin of -17.23%. Precipio's return on equity of -34.01% beat Aethlon Medical's return on equity.Company Net Margins Return on Equity Return on Assets Aethlon MedicalN/A -160.36% -115.74% Precipio -17.23%-34.01%-25.27% Does the media refer more to AEMD or PRPO? In the previous week, Aethlon Medical had 8 more articles in the media than Precipio. MarketBeat recorded 10 mentions for Aethlon Medical and 2 mentions for Precipio. Precipio's average media sentiment score of 1.37 beat Aethlon Medical's score of 0.06 indicating that Precipio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Precipio 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, AEMD or PRPO? Precipio has higher revenue and earnings than Aethlon Medical. Precipio is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAethlon Medical$570K9.66-$12.21M-$2.82-0.14Precipio$15.20M0.58-$5.85M-$1.83-3.28 Does the MarketBeat Community believe in AEMD or PRPO? Precipio received 54 more outperform votes than Aethlon Medical when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 52.28% of users gave Aethlon Medical an outperform vote. CompanyUnderperformOutperformAethlon MedicalOutperform Votes21852.28% Underperform Votes19947.72% PrecipioOutperform Votes27273.32% Underperform Votes9926.68% SummaryPrecipio beats Aethlon Medical on 10 of the 18 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEMD vs. The Competition Export to ExcelMetricAethlon MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.51M$4.42B$5.06B$8.82BDividend YieldN/A41.17%5.18%4.07%P/E Ratio-0.1424.81126.3117.81Price / Sales9.6647.031,178.7474.57Price / CashN/A51.8733.8632.53Price / Book0.184.974.684.68Net Income-$12.21M$13.76M$119.54M$226.08M7 Day Performance-1.00%-1.08%-1.83%-1.04%1 Month Performance-3.17%0.58%-3.60%1.04%1 Year Performance-76.45%50.91%31.91%26.28% Aethlon Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEMDAethlon Medical2.6602 of 5 stars$0.39-1.3%$7.00+1,718.2%-77.2%$5.38M$570,000.00-0.1410PRPOPrecipio1.2245 of 5 stars$6.00-2.3%N/A-15.8%$8.88M$15.20M0.0060Positive NewsGap DownMDAISpectral AI2.7744 of 5 stars$1.09+2.8%$4.50+312.8%-59.4%$20.26M$18.06M0.0078IINNInspira Technologies Oxy B.H.N.0.3151 of 5 stars$1.37+3.8%N/A+11.3%$17.29MN/A0.0020News CoveragePYPDPolyPid2.8681 of 5 stars$3.49-3.1%$12.00+243.8%-14.3%$16.75MN/A0.0080Positive NewsHigh Trading VolumeLFWDReWalk Robotics3.5648 of 5 stars$1.86+0.5%$13.00+598.9%N/A$16.39M$13.85M-0.7460Gap DownMHUAMeihua International Medical Technologies0.3475 of 5 stars$0.64-1.4%N/A-66.4%$16.05M$97.10M0.00620Gap UpMBOTMicrobot Medical1.7232 of 5 stars$0.94+2.3%$7.00+644.1%-32.8%$15.93MN/A-1.1520Negative NewsNEPHNephros2.2003 of 5 stars$1.50-5.7%$5.00+233.3%-24.3%$15.81M$14.24M0.0030Gap UpAMIXAutonomix Medical2.2386 of 5 stars$13.48+0.9%$28.00+107.7%N/A$15.50MN/A0.001VVOSVivos Therapeutics2.1857 of 5 stars$2.87-0.7%$6.30+119.5%-34.2%$13.89M$13.80M0.00160Analyst Forecast Related Companies and Tools Related Companies PRPO Alternatives MDAI Alternatives IINN Alternatives PYPD Alternatives LFWD Alternatives MHUA Alternatives MBOT Alternatives NEPH Alternatives AMIX Alternatives VVOS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AEMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.